Abbvie Inc
NYSE:ABBV
Abbvie Inc
Other Items
Abbvie Inc
Other Items Peer Comparison
Competitive Other Items Analysis
Latest Figures & CAGR of Competitors
Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Other Items
$-1.2B
|
CAGR 3-Years
68%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Items
$-1.7B
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-39%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Items
$-25.1B
|
CAGR 3-Years
-74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Items
$-2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-93%
|
CAGR 10-Years
-101%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Items
$-2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-27%
|
|
Seagen Inc
NASDAQ:SGEN
|
Other Items
$632.5m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
75%
|
See Also
What is Abbvie Inc's Other Items?
Other Items
-1.2B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Other Items amounts to -1.2B USD.
What is Abbvie Inc's Other Items growth rate?
Other Items CAGR 5Y
-27%
The average annual Other Items growth rates for Abbvie Inc have been 68% over the past three years , -27% over the past five years .